CLASS II Device recall · Reported 26 Feb 2020 · FDA Enforcement Report

i-STAT CG4+ cartridge (blue), List No. 03P85 recalled

Abbott Point Of Care is recalling i-STAT CG4+ cartridge (blue), List No. 03P85-50, distributed nationwide in the US. The recall was initiated on 15 Jan 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots are affected
Quantity recalled99,850

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1263-2020
FDA event ID
84728
Recalling firm
Abbott Point Of Care, Princeton, NJ
Classification
Class II
Status
Terminated
Recall initiated
15 Jan 2020
FDA classified
18 Feb 2020
Reported
26 Feb 2020
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

15 Jan 2020Recall initiated by company
18 Feb 2020Classified by FDA+34 days
26 Feb 2020Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards apply to waived and non-waived tests as well as the facilities that perform these types of tests. The i-STAT CHEM8+ cartridge contains nine measured assays (sodium, potassium, chloride, blood urea nitrogen (BUN), ionized calcium, TCO2, glucose, creatinine and hematocrit) and is categorized as a CLIA waived test for venous whole blood samples, meaning this cartridge could be used in a facility with a CLIA Certificate of Waiver as a waived test.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

i-STAT CG4+ cartridge (blue), List No. 03P85-50. UDI (01) 00054749002269 - Product Usage: The i-STAT CG4+ cartridge is intended for the quantitative measurement of lactate, pH, pCO2, and pO2 in venous, arterial or capillary whole blood.

Where it was distributed

US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards apply to waived and non-waived tests as well as the facilities that perform these types of tests. The i-STAT CHEM8+ cartridge contains nine measured assays (sodium, potassium, chloride, blood urea nitrogen (BUN), ionized calcium, TCO2, glucose, creatinine and hematocrit) and is categorized as a CLIA waived test for venous whole blood samples, meaning this cartridge could be used in a facility with a CLIA Certificate of Waiver as a waived test.

Which lots are affected?

All lots are affected

Where was it sold?

US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 84728
ReportedClassRecallCompanyReasonWhere
CLASS IIi-STAT CHEM8+ cartridges (blue), List No. 09P31 recalledAbbott Point Of CarePotency & AssayNationwide

More recalls from Abbott Point Of Care

All 31

Other Other Medical Devices recalls

All 13,884